Cargando…

Long-term clinical course of a patient with mucopolysaccharidosis type IIIB

Mucopolysaccharidosis type III (MPS III) is a rare genetic disorder caused by lysosomal storage of heparan sulfate. MPS IIIB results from a deficiency in the enzyme alpha-N-acetyl-D-glucosaminidase (NAGLU). Affected patients begin showing behavioral changes, progressive profound mental retardation,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ja Hye, Chi, Yang Hyun, Kim, Gu-Hwan, Yoo, Han-Wook, Lee, Jun Hwa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Pediatric Society 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5177708/ https://www.ncbi.nlm.nih.gov/pubmed/28018442 http://dx.doi.org/10.3345/kjp.2016.59.11.S37

Ejemplares similares

An Uncommon Presentation of Mucopolysaccharidosis Type IIIb
por: REZAYI, Alireza, et al.
Publicado: (2019)

A model of mucopolysaccharidosis type IIIB in pigs
por: Yang, Qiang, et al.
Publicado: (2018)

The neurobehavioral phenotype in mucopolysaccharidosis Type IIIB: An exploratory study
por: Shapiro, E., et al.
Publicado: (2016)

Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype
por: Valstar, Marlies J., et al.
Publicado: (2010)

Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB
por: Wilkinson, Fiona L., et al.
Publicado: (2012)

Proteomic Analysis of Mucopolysaccharidosis IIIB Mouse Brain
por: De Pasquale, Valeria, et al.
Publicado: (2020)

Disease pathology signatures in a mouse model of Mucopolysaccharidosis type IIIB
por: Petrova, Ralitsa, et al.
Publicado: (2023)

Activation of Stress Kinases in the Brain of Mucopolysaccharidosis IIIB mice
por: Cecere, Francesca, et al.
Publicado: (2011)

Heparan Sulfate, Mucopolysaccharidosis IIIB and Sulfur Metabolism Disorders
por: Kaczor-Kamińska, Marta, et al.
Publicado: (2022)

Mucopolysaccharidosis type IIIB: a current review and exploration of the AAV therapy landscape
por: Rouse, Courtney J., et al.
Publicado: (2023)

An exonic insertion in the NAGLU gene causing Mucopolysaccharidosis IIIB in Schipperke dogs
por: Raj, Karthik, et al.
Publicado: (2020)

Case report of Chromosome 3q25 deletion syndrome or Mucopolysaccharidosis IIIB
por: Chang, Yu-Tzu, et al.
Publicado: (2014)

Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases
por: Belfiore, Maria Paola, et al.
Publicado: (2020)

A Novel Mutation (c.200T>C) in the NAGLU Gene of a Korean Patient with Mucopolysaccharidosis IIIB
por: Kim, Young-Eun, et al.
Publicado: (2013)

Clinical course of sly syndrome (mucopolysaccharidosis type VII)
por: Montaño, Adriana M, et al.
Publicado: (2016)

The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure
por: Schiattarella, Gabriele Giacomo, et al.
Publicado: (2015)

Residual N-acetyl-α-glucosaminidase activity in fibroblasts correlates with disease severity in patients with mucopolysaccharidosis type IIIB
por: Meijer, O. L. M., et al.
Publicado: (2016)

Cell-Mediated Immunity to NAGLU Transgene Following Intracerebral Gene Therapy in Children With Mucopolysaccharidosis Type IIIB Syndrome
por: Gougeon, Marie-Lise, et al.
Publicado: (2021)

Tralesinidase Alfa Enzyme Replacement Therapy Prevents Disease Manifestations in a Canine Model of Mucopolysaccharidosis Type IIIB
por: Ellinwood, N. Matthew, et al.
Publicado: (2022)

Early Neurodegeneration Progresses Independently of Microglial Activation by Heparan Sulfate in the Brain of Mucopolysaccharidosis IIIB Mice
por: Ausseil, Jérôme, et al.
Publicado: (2008)

Peripheral Nervous System Neuropathology and Progressive Sensory Impairments in a Mouse Model of Mucopolysaccharidosis IIIB
por: Fu, Haiyan, et al.
Publicado: (2012)

Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune response
por: Killedar, Smruti, et al.
Publicado: (2010)

Electrophysiological and Histological Characterization of Rod-Cone Retinal Degeneration and Microglia Activation in a Mouse Model of Mucopolysaccharidosis Type IIIB
por: Tse, Dennis Y., et al.
Publicado: (2015)

Once in a Blue Moon, a Very Rare Coexistence of Glutaric Acidemia Type I and Mucopolysaccharidosis Type IIIB in a Patient
por: Alaei, Mohammad Reza, et al.
Publicado: (2020)

Mucopolysaccharidosis IIIB confers enhanced neonatal intracranial transduction by AAV8 but not by 5, 9 or rh10
por: Gilkes, J A, et al.
Publicado: (2016)

EGFR activation triggers cellular hypertrophy and lysosomal disease in NAGLU-depleted cardiomyoblasts, mimicking the hallmarks of mucopolysaccharidosis IIIB
por: De Pasquale, Valeria, et al.
Publicado: (2018)

Mucopolysaccharidosis IIIB and mild skeletal anomalies: coexistence of NAGLU and CYP26B1 missense variations in the same patient in a Chinese family
por: Li, Jinliang, et al.
Publicado: (2018)

Long-term clinical outcome and the identification of homozygous CYP27B1 gene mutations in a patient with vitamin D hydroxylation-deficient rickets type 1A
por: Cho, Ja Hyang, et al.
Publicado: (2016)

Differential distribution of heparan sulfate glycoforms and elevated expression of heparan sulfate biosynthetic enzyme genes in the brain of mucopolysaccharidosis IIIB mice
por: McCarty, Douglas M., et al.
Publicado: (2011)

Mucopolysaccharidosis Type I
por: Kubaski, Francyne, et al.
Publicado: (2020)

Targeted Metabolomic Analysis of a Mucopolysaccharidosis IIIB Mouse Model Reveals an Imbalance of Branched-Chain Amino Acid and Fatty Acid Metabolism
por: De Pasquale, Valeria, et al.
Publicado: (2020)

Long-term follow-up on Cushing disease patient after transsphenoidal surgery
por: Jeong, Insook, et al.
Publicado: (2014)

Skewed X-Chromosome Inactivation in a Korean Girl with Severe Mucopolysaccharidosis Type II
por: Kim, Hwa Young, et al.
Publicado: (2022)

Clinical, Biochemical, and Genetic Characterization of Glycogen Storage Type IX in a Child with Asymptomatic Hepatomegaly
por: Kim, Jung Ah, et al.
Publicado: (2015)

Clinical characteristics and effects of enzyme replacement therapy with elosulfase alfa in Korean patients with mucopolysaccharidosis type IVA
por: Lee, Seung Hoon, et al.
Publicado: (2022)

Osteoarthropathy in mucopolysaccharidosis type II
por: NASCU, IOANA, et al.
Publicado: (2013)

Analysis of long-term observations of the large group of Russian patients with Hunter syndrome (mucopolysaccharidosis type II)
por: Semyachkina, Alla Nikolaevna, et al.
Publicado: (2021)

Real world long-term outcomes in patients with mucopolysaccharidosis type II: A retrospective cohort study
por: Tomita, Kazuyoshi, et al.
Publicado: (2021)

Natural history of cognitive development in neuronopathic mucopolysaccharidosis type II (Hunter syndrome): Contribution of genotype to cognitive developmental course
por: Seo, Joo-Hyun, et al.
Publicado: (2020)

Long-term efficacy of recombinant human growth hormone therapy in short-statured patients with Noonan syndrome
por: Jeong, Insook, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p7gcs4mc62r5rperhn28jl4fv0